<?xml version="1.0" encoding="UTF-8"?>
<p id="Par81">Finally, taking into account all abovementioned challenges, the tunable properties of MSNs and recent advances regarding smart and multi stimuli-responsive MSNs for diagnosis, therapy or theranostic applications, we can expect in the next years MSNs-based nanoplatforms and other silica-based nanosystems will become approved by FDA, impacting the treatment way and global human health.</p>
